We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Drug-Resistant Bacteria Defeated by Trojan Horse Strategy

By HospiMedica staff writers
Posted on 02 Apr 2007
A novel antimicrobial approach can kill bacteria in laboratory experiments and eliminate life-threatening infections in mice by interfering with a key bacterial nutrient, according to a new study.

Researchers at the University of Washington (UW; Seattle, USA), the University of Iowa (Iowa City, USA), and the University of Cincinnati (OH, USA) sought to intensify the stress imposed on microbes by interruption of their iron supply. More...
The researchers achieved this by using gallium, a metal very similar to iron. A critical element in the growth of bacteria, iron is needed by bacteria to enable them to form biofilms (slime-encased colonies of microbes that cause many chronic infections).

The researchers showed that gallium killed microbes, and prevented the formation of biofilms. The gallium's action was intensified in low iron conditions, like those that exist in the human body. Gallium was even effective against strains of Pseudomonas aeruginosa collected from cystic fibrosis (CF) patients that were resistant to multiple antibiotics. In mice, gallium treatment blocked both chronic and acute infections caused by this bacterium. The study was published in the April 2, 2007, issue of the Journal of Clinical Investigation.

"The competition for iron is critical in the struggle between bacteria and host,” said senior author Pradeep Singh, M.D., Ph.D., associate professor of medicine and microbiology at the UW. "Gallium acts as a Trojan horse to iron-seeking bacteria. Because gallium looks like iron, invading bacteria are tricked, in a way, into taking it up. Unfortunately for the bacteria, gallium can't function like iron once it's inside bacterial cells.”

"We badly need new approaches to fight bacteria,” concluded Dr. Singh. "The gallium strategy isn't ready for clinical use yet. However, we think this approach is promising, and we can't afford to leave any stone unturned.”


Related Links:
University of Washington
University of Iowa
University of Cincinnati

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.